Arkolith/Insider Trading/NAVB/Form 4

Scott John K Jr.

Director, 10% OwnerNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Jun 15, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2023Grant(A)11.5M——19.6M
Jun 1, 2023Other(J)990——2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2023Conversion(C)12K$100.00$1.2M0
Jun 1, 2023Buy(P)12K$100.00$1.2M12K

Transaction Codes

A
Grant / award
J
Other acquisition / disposition
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-017587) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML